| CGARX | CGGGX | CGARX / CGGGX | |
| Total Expense Ratio | 0.64 | 0.69 | 93% |
| Annual Report Gross Expense Ratio | 0.64 | 0.74 | 86% |
| Fund Existence | 4 years | 7 years | - |
| Gain YTD | 14.542 | 22.207 | 65% |
| Front Load | N/A | 6% | - |
| Min. Initial Investment | 5000000 | 250 | 2,000,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 371M | 7.21B | 5% |
| Annual Yield % from dividends | 1.43 | 0.62 | 232% |
| Returns for 1 year | 10.86 | 15.64 | 69% |
| Returns for 3 years | 38.72 | 52.99 | 73% |
| Returns for 5 years | N/A | 39.96 | - |
| Returns for 10 years | N/A | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| NRIQX | 15.04 | 0.08 | +0.53% |
| Neuberger Berman International Eq R6 | |||
| DIECX | 47.39 | 0.19 | +0.40% |
| BNY Mellon International Core Equity C | |||
| FNNEX | 79.14 | 0.21 | +0.27% |
| American Funds New Economy 529-F-3 | |||
| GALLX | 21.59 | N/A | N/A |
| Goldman Sachs Enhanced U.S. Equity A | |||
| PMEGX | 62.50 | -0.03 | -0.05% |
| T. Rowe Price Instl Mid-Cap Equity Gr | |||